ProfileGDS4718 / 223426_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 89% 89% 61% 91% 91% 79% 70% 89% 93% 92% 89% 93% 82% 79% 78% 84% 92% 78% 77% 80% 89% 91% 90% 90% 86% 81% 94% 82% 91% 77% 79% 71% 92% 90% 66% 76% 84% 88% 91% 56% 91% 80% 73% 75% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.0306489
GSM549102patient 115, normal, homogenized [OPG study]9.042389
GSM549104patient 119, normal, homogenized [OPG study]6.2348461
GSM549108patient 138, normal, homogenized [OPG study]9.2300991
GSM549119patient 077, normal, homogenized [OPG study]9.4919191
GSM549133patient 032, cancer, homogenized [OPG study]7.9346979
GSM549139patient 042, cancer, homogenized [OPG study]6.9090670
GSM549099patient 107, normal, homogenized [OPG study]9.0388289
GSM549109patient 139, normal, homogenized [OPG study]9.7142293
GSM549110patient 046, normal, homogenized [OPG study]9.5607292
GSM549114patient 063, normal, homogenized [OPG study]9.2220889
GSM549122patient 082, normal, homogenized [OPG study]9.8372393
GSM549134patient 033, cancer, homogenized [OPG study]8.1079982
GSM549136patient 036, cancer, homogenized [OPG study]7.8109279
GSM549140patient 044, cancer, homogenized [OPG study]7.7183778
GSM549111patient 047, normal, homogenized [OPG study]8.3963684
GSM549113patient 057, normal, homogenized [OPG study]9.8103392
GSM549132patient 031, cancer, homogenized [OPG study]7.7041778
GSM549137patient 038, cancer, homogenized [OPG study]7.5877877
GSM549142patient 047, cancer, homogenized [OPG study]7.6101780
GSM549100patient 110, normal, homogenized [OPG study]9.0246589
GSM549107patient 135, normal, homogenized [OPG study]9.4427791
GSM549115patient 068, normal, homogenized [OPG study]9.4488890
GSM549116patient 072, normal, homogenized [OPG study]9.311690
GSM549120patient 078, normal, homogenized [OPG study]8.6486286
GSM549131patient 030, cancer, homogenized [OPG study]8.1349681
GSM549118patient 074, normal, homogenized [OPG study]10.131794
GSM549129patient 027, cancer, homogenized [OPG study]8.1120782
GSM549123patient 088, normal, homogenized [OPG study]9.3838591
GSM549124patient 006, cancer, homogenized [OPG study]7.512377
GSM549126patient 015, cancer, homogenized [OPG study]7.7266679
GSM549128patient 025, cancer, homogenized [OPG study]7.0374771
GSM549103patient 117, normal, homogenized [OPG study]9.5329892
GSM549117patient 073, normal, homogenized [OPG study]9.3848290
GSM549138patient 041, cancer, homogenized [OPG study]6.5509366
GSM549141patient 045, cancer, homogenized [OPG study]7.5207176
GSM549130patient 028, cancer, homogenized [OPG study]8.3260584
GSM549101patient 111, normal, homogenized [OPG study]8.8885688
GSM549105patient 128, normal, homogenized [OPG study]9.298891
GSM549106patient 134, normal, homogenized [OPG study]5.8109356
GSM549112patient 048, normal, homogenized [OPG study]9.4789591
GSM549125patient 011, cancer, homogenized [OPG study]7.766980
GSM549127patient 024, cancer, homogenized [OPG study]7.25173
GSM549135patient 035, cancer, homogenized [OPG study]7.438975